|
Index of reports
> Cases resulting in disability (16)
Below is the selection of adverse event reports related to Carbamazepine that includes cases resulting in disability.
Adverse event in 32 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from Brazil on 2007-10-15
Patient: 32 year old female
Adverse reactions / side effects: Cholestasis, Condition Aggravated, Depression, Hepatitis, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Copaxone
Dosage: 20 mg (20 mg, 1-2) subcutaneous, 20 mg (20 mg, 1 in 1 d), subcutaneous
Indication: Multiple Sclerosis
Start date: 2005-09-29
End date: 2005-10-17
Copaxone
Dosage: 20 mg (20 mg, 1-2) subcutaneous, 20 mg (20 mg, 1 in 1 d), subcutaneous
Indication: Multiple Sclerosis
Start date: 2005-10-31
Interferon Beta
Dosage: double blind: 250 or 500 microgram
Indication: Relapsing-Remitting Multiple Sclerosis
Start date: 2005-07-25
End date: 2005-09-22
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified)
Indication: Convulsion
Start date: 2005-09-16
End date: 2005-09-16
Phenytoin
Dosage: 300 mg (300 mg, 1 in 1 d); oral, 300 mg (300 mg, 1 in 1 d); oral
Administration route: Oral
Start date: 2005-09-17
End date: 2005-09-18
Phenytoin
Dosage: 300 mg (300 mg, 1 in 1 d); oral, 300 mg (300 mg, 1 in 1 d); oral
Administration route: Oral
Start date: 2005-09-20
End date: 2005-09-21
Fluoxetine
Dosage: 20 mg (20 mg, 1 in 1 d); oral
Administration route: Oral
Indication: Depression
Start date: 2005-06-27
End date: 2005-09-02
Chlorpromazine
Dosage: 50 mg (50 mg, 1 in 1 d); intravenous (not otherwise specified)
Indication: Depression
Start date: 2005-09-21
End date: 2005-09-26
Carbamazepine
Dosage: 800 mg (400 mg, 2 in 1 d); oral
Administration route: Oral
Indication: Convulsion
Start date: 2005-09-22
End date: 2005-10-17
Amitriptyline HCL
Dosage: 50 mg, (50 mg, 1 in 1 d); oral
Administration route: Oral
Indication: Depression
Start date: 2005-09-27
End date: 2005-10-12
Other drugs received by patient: Diane; Captopril; Diazepam; Belacodid; Prednisone; Diclofenac; Sertraline; Clonazepam; Ibuprofen; Paracetamol; Dimenhydrinate; Dipyron; Tramadol HCL; Metoclopramide; Ranitidine HCL; Sodium Chloride
Adverse event in 32 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from Brazil on 2007-10-01
Patient: 32 year old female
Adverse reactions / side effects: Hepatic Enzyme Abnormal, Hepatic Function Abnormal, Pyoderma, Cholestasis, Hepatitis, Septic Shock, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Copaxone
Dosage: 20 mg (20 mg, 1 in 1 d)
Indication: Multiple Sclerosis
Start date: 2005-09-29
End date: 2005-10-22
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified); 300 mg (300 mg, 1 in 1 d) oral
Indication: Convulsion
Start date: 2005-09-16
End date: 2005-09-16
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified); 300 mg (300 mg, 1 in 1 d) oral
Indication: Convulsion
Start date: 2005-09-17
End date: 2005-09-18
Phenytoin
Dosage: 1 gram (1 gram, 1 in 1 d) intravenous (not otherwise specified); 300 mg (300 mg, 1 in 1 d) oral
Indication: Convulsion
Start date: 2005-09-20
End date: 2005-09-21
Fluoxetine
Dosage: 20 mg (20 mg, 1 in 1 d)
Administration route: Oral
Indication: Depression
Start date: 2005-06-27
End date: 2005-09-02
Chlorpromazine
Dosage: 50 (50 mg, 1 in 1 d) intravenous (not otherwise specified)
Indication: Depression
Start date: 2005-09-21
End date: 2005-09-26
Carbamazepine
Dosage: 800 mg (400 mg, 2 in 1 d)
Administration route: Oral
Indication: Convulsion
Start date: 2005-09-22
End date: 2005-10-17
Amitriptyline HCL
Dosage: 50 mg (50 mg, 1 in 1 d)
Administration route: Oral
Indication: Depression
Start date: 2005-09-27
End date: 2005-10-12
Other drugs received by patient: Diane; Captopril; Diazepam; Belacodid; Prednisone; Diclofenac Sodium; Sertraline; Clonazepam; Ibuprofen; Paracetamol; Dimenhydrinate; Dipyron; Tramadol HCL; Metoclopramide; Ranitidine HCL; Sodium Chloride
Adverse event in 7 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from United States on 2007-07-27
Patient: 7 year old female
Adverse reactions / side effects: Irritability, Muscle Spasticity, Somnolence, Pharmaceutical Product Complaint, Oxygen Saturation Decreased, Lethargy
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Carbamazepine
Other drugs received by patient: Risperdal; Topamax; Chloral Hydrate (Chloral Hydrate); Valium; Omnicef
Adverse event in 62 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-27
Patient: 62 year old female, weighing 145.0 kg (319.0 pounds)
Adverse reactions / side effects: Vomiting, Loss of Consciousness, Mobility Decreased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Carbamazepine
Other drugs received by patient: Citalopram Hydrobromide; Levetiracetam; Rosuvastatin
Adverse event in male receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-05
Patient: male, weighing 1.6 kg (3.5 pounds)
Adverse reactions / side effects: Cleft LIP, Micrognathia
Adverse event resulted in: disablity
Suspect drug(s):
Rivotril
End date: 2007-01-31
Carbamazepine
End date: 2007-01-31
Epitomax
End date: 2007-01-31
DI-Hydan
End date: 2007-01-31
Other drugs received by patient: Depakene
Adverse event in receiving Carbamazepine
Reported by a individual with unspecified qualification from Italy on 2007-06-29
Patient:
Adverse reactions / side effects: Congenital Nose Malformation, Congenital Renal Cyst, Dysmorphism, Drug Exposure During Pregnancy, Prominent Epicanthal Folds, Hypertelorism of Orbit, Renal Dysplasia, Renal Hypertrophy
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Carbamazepine
Dosage: oral
Administration route: Oral
Indication: Epilepsy
Phenobarbital TAB
Dosage: oral
Administration route: Oral
Indication: Epilepsy
Adverse event in receiving Carbamazepine
Reported by a individual with unspecified qualification from Italy on 2007-06-29
Patient:
Adverse reactions / side effects: Pelvic Mass, Dysmorphism, LIP Disorder, Renal Impairment Neonatal, Prominent Epicanthal Folds, Renal Dysplasia, Renal Hypertrophy, Drug Exposure During Pregnancy, Congenital Anomaly, Congenital Cystic Kidney Disease
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Carbamazepine
Dosage: oral
Administration route: Oral
Indication: Epilepsy
Phenobarbital TAB
Dosage: oral
Administration route: Oral
Indication: Epilepsy
Adverse event in receiving Carbamazepine
Reported by a individual with unspecified qualification from Italy on 2007-06-29
Patient:
Adverse reactions / side effects: Dysmorphism, Renal Impairment Neonatal, Hypertelorism of Orbit, Renal Dysplasia, Renal Hypertrophy, Drug Exposure During Pregnancy, Congenital Anomaly, Congenital Cystic Kidney Disease
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Carbamazepine
Indication: Epilepsy
Phenobarbital TAB
Indication: Epilepsy
Adverse event in receiving Carbamazepine
Reported by a individual with unspecified qualification from Italy on 2007-06-29
Patient:
Adverse reactions / side effects: Dysmorphism, Renal Impairment Neonatal, Prominent Epicanthal Folds, Hypertelorism of Orbit, Renal Dysplasia, Renal Hypertrophy, Drug Exposure During Pregnancy, Congenital Anomaly, Congenital Cystic Kidney Disease
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Carbamazepine
Dosage: oral
Administration route: Oral
Indication: Epilepsy
Phenobarbital TAB
Dosage: oral
Administration route: Oral
Indication: Epilepsy
Adverse event in male receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-22
Patient: male, weighing 1.6 kg (3.5 pounds)
Adverse reactions / side effects: Cleft LIP, Premature Baby, Micrognathia, Pierre Robin Syndrome, Foetal Growth Retardation
Adverse event resulted in: disablity
Suspect drug(s):
Epitomax
Indication: Drug Exposure During Pregnancy
DI-Hydan
Indication: Drug Exposure During Pregnancy
Rivotril
Indication: Drug Exposure During Pregnancy
Carbamazepine
Indication: Drug Exposure During Pregnancy
Other drugs received by patient: Depakene
Adverse event in 60 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from United States on 2007-05-31
Patient: 60 year old female
Adverse reactions / side effects: Bipolar Disorder, Mental Disorder, Condition Aggravated, Convulsion
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Carbamazepine
Other drugs received by patient: Lithium Carbonate; Risperdal; Prozac
Adverse event in 60 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from United States on 2007-04-30
Patient: 60 year old female
Adverse reactions / side effects: Impaired Driving Ability, Mental Disability, Condition Aggravated, Convulsion
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Carbamazepine
Adverse event in 30 year old female receiving Carbamazepine
Reported by a individual with unspecified qualification from Turkey on 2007-03-30
Patient: 30 year old female
Adverse reactions / side effects: Balance Disorder, Dizziness, Hyponatraemia, Sinusitis, Lethargy
Adverse event resulted in: disablity
Suspect drug(s):
Carbamazepine
Dosage: 200mg, bid, oral
Administration route: Oral
Indication: Epilepsy
Clarithromycin
Dosage: 500mg, bid, oral
Administration route: Oral
Indication: Sinusitis
Adverse event in female receiving Carbamazepine
Reported by a physician from Germany on 2007-03-16
Patient: female, weighing 51.0 kg (112.2 pounds)
Adverse reactions / side effects: Anticonvulsant Drug Level Above Therapeutic, Anticonvulsant Drug Level Below Therapeutic
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Keppra
Dosage: 1 g 3/d;po
Administration route: Oral
Start date: 2006-10-01
Valproic Acid
Dosage: 500 mg 6/d;po
Administration route: Oral
Carbamazepine
Dosage: 400 mg;po
Administration route: Oral
Start date: 2007-02-07
End date: 2007-02-27
Adverse event in 80 year old female receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from Norway on 2007-01-19
Patient: 80 year old female
Adverse reactions / side effects: Paraplegia, Spinal Epidural Haemorrhage, Drug Interaction
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Zocor
Diclofenac Sodium
Administration route: Oral
Levothyroxine Sodium
Administration route: Oral
Warfarin Sodium
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2006-11-30
Acetaminophen
Administration route: Oral
Carbamazepine
Administration route: Oral
Other drugs received by patient: Morphine Hydrochloride; Gabapentin
Adverse event in 80 year old female receiving Carbamazepine
Reported by a health professional (non-physician/pharmacist) from Norway on 2007-01-16
Patient: 80 year old female
Adverse reactions / side effects: Paraplegia, Spinal Epidural Haemorrhage, Drug Interaction
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Zocor
Diclofenac Sodium
Administration route: Oral
Levothyroxine Sodium
Administration route: Oral
Warfarin Sodium
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2006-11-30
Acetaminophen
Administration route: Oral
Carbamazepine
Administration route: Oral
Other drugs received by patient: Morphine Hydrochloride; Gabapentin
|
